XML 28 R12.htm IDEA: XBRL DOCUMENT
v3.23.3

Per Share Information | 12 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
Earnings Per Share [Text Block] | 6. PER SHARE INFORMATION Basic earnings per share is calculated as income (loss) available to common stockholders, divided by the weighted average number of common shares outstanding during the period. If the effect is dilutive, participating securities are included in the computation of basic earnings per share. Our participating securities do not have a contractual obligation to share in the losses in any given period. As a result, these participating securities will not be allocated any losses in the periods of net losses, but will be allocated income in the periods of net income using the two-class method. The following table reconciles the components of the basic and diluted earnings per share for the years ended September 30, 2023, 2022 and 2021:
| Year Ended September 30,
| 2023 |  | 2022 |  | 2021
Numerator: |  |  |  |  |
Net income attributable to IES Holdings, Inc. | $ | 108,288 |  |  | $ | 34,762 |  |  | $ | 66,658 |
Increase in noncontrolling interest | (15,701) |  |  | (4,695) |  |  | (315) |
Net income attributable to restricted shareholders of IES Holdings, Inc. | (11) |  |  | (21) |  |  | (56) |
Net income attributable to common shareholders of IES Holdings, Inc. | $ | 92,576 |  |  | $ | 30,046 |  |  | $ | 66,287 |
Denominator: |  |  |  |  |
Weighted average common shares outstanding — basic | 20,196,850 |  |  | 20,667,745 |  |  | 20,790,307 |
Effect of dilutive stock options and non-vested securities | 216,182 |  |  | 226,880 |  |  | 296,125 |
Weighted average common and common equivalent shares outstanding — diluted | 20,413,032 |  |  | 20,894,625 |  |  | 21,086,432 |
Earnings per share attributable to common shareholders of IES Holdings, Inc.: |  |  |  |  |
Basic | $ | 4.58 |  |  | $ | 1.45 |  |  | $ | 3.19 |
Diluted | $ | 4.54 |  |  | $ | 1.44 |  |  | $ | 3.15 |
For the years ended September 30, 2023, 2022 and 2021, the average price of our common stock exceeded the exercise price of outstanding stock options; therefore, all of our outstanding stock options were included in the computation of diluted earnings per share. For the years ended September 30, 2023, 2022 and 2021, there were no other unvested performance awards excluded from the calculation of diluted earnings per share because the inclusion of such instruments would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration